Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals.

Various proteins with different biological activities have been observed to be translocated from the nucleus to the cytoplasm in an energy- and signal-dependent manner in eukaryotic cells. This nuclear export is directed by nuclear export signals (NESs), typically characterized by hydrophobic, primarily leucine, amino acid residues. Moreover, it has been shown that CRM1/exportin 1 is an export receptor for leucine-rich NESs. However, additional NES-interacting proteins have been described. In particular, eukaryotic initiation factor 5A (eIF-5A) has been shown to be a critical cellular cofactor for the nuclear export of the HIV type 1 (HIV-1) Rev trans-activator protein. In this study we compared the nuclear export activity of NESs of different origin. Microinjection of export substrates into the nucleus of somatic cells in combination with specific inhibitors indicated that specific nuclear export pathways exist for different NES-containing proteins. In particular, inhibition of eIF-5A blocked the nuclear export of NESs derived from the HIV-1 Rev and human T cell leukemia virus type I Rex trans-activators, whereas nucleocytoplasmic translocation of the protein kinase inhibitor-NES was unaffected. In contrast, however, inhibition of CRM1/exportin 1 blocked the nuclear export of all NES-containing proteins investigated. Our data confirm that CRM1/exportin 1 is a general export receptor for leucine-rich NESs and suggest that eIF-5A acts either upstream of CRM1/exportin 1 or forms a complex with the NES and CRM1/exportin 1 in the nucleocytoplasmic translocation of the HIV-1 Rev and human T cell leukemia virus type I Rex RNA export factors.

[1]  A. Zolotukhin,et al.  Nucleoporins Nup98 and Nup214 Participate in Nuclear Export of Human Immunodeficiency Virus Type 1 Rev , 1999, Journal of Virology.

[2]  Jørgen Kjems,et al.  The Specificity of the CRM1-Rev Nuclear Export Signal Interaction Is Mediated by RanGTP* , 1998, The Journal of Biological Chemistry.

[3]  B. Paschal,et al.  A cytosolic activity distinct from crm1 mediates nuclear export of protein kinase inhibitor in permeabilized cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Levine,et al.  Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.

[5]  B. Cullen,et al.  Inhibition of Human Immunodeficiency Virus Rev and Human T-Cell Leukemia Virus Rex Function, but Not Mason-Pfizer Monkey Virus Constitutive Transport Element Activity, by a Mutant Human Nucleoporin Targeted to Crm1 , 1998, Journal of Virology.

[6]  M. Yanagida,et al.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.

[7]  J. Moore,et al.  Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. , 1998, Genes & development.

[8]  M. Gaestel,et al.  Leptomycin B‐sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation , 1998, The EMBO journal.

[9]  E. Nishida,et al.  Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint , 1998, The EMBO journal.

[10]  D. Görlich.  Transport into and out of the cell nucleus , 1998, The EMBO journal.

[11]  F. Melchior,et al.  Two-way trafficking with Ran. , 1998, Trends in cell biology.

[12]  A. Lamond,et al.  Structure and function in the nucleus. , 1998, Science.

[13]  E. Nishida,et al.  Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein , 1998, The EMBO journal.

[14]  G. Grosveld,et al.  Overexpression of the Nucleoporin CAN/NUP214 Induces Growth Arrest, Nucleocytoplasmic Transport Defects, and Apoptosis , 1998, Molecular and Cellular Biology.

[15]  J. Hauber,et al.  Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Fornerod,et al.  Nucleocytoplasmic Transport: The Last 200 Nanometers , 1998, Cell.

[17]  A. Dayton,et al.  Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev. , 1998, Biochemical and biophysical research communications.

[18]  M. Malim,et al.  The HIV-1 Rev protein. , 1998, Annual review of microbiology.

[19]  Minoru Yoshida,et al.  CRM1 is responsible for intracellular transport mediated by the nuclear export signal , 1997, Nature.

[20]  C. Dargemont,et al.  Evidence for a role of CRM1 in signal-mediated nuclear protein export. , 1997, Science.

[21]  M. Rosbash,et al.  The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export , 1997, Current Biology.

[22]  Minoru Yoshida,et al.  CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.

[23]  Karsten Weis,et al.  Exportin 1 (Crm1p) Is an Essential Nuclear Export Factor , 1997, Cell.

[24]  P. Silver,et al.  Nucleocytoplasmic transport of macromolecules , 1997, Microbiology and molecular biology reviews : MMBR.

[25]  Erich A. Nigg,et al.  Nucleocytoplasmic transport: signals, mechanisms and regulation , 1997, Nature.

[26]  M. Fornerod,et al.  The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88 , 1997, The EMBO journal.

[27]  Y. Wang,et al.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.

[28]  M. Fornerod,et al.  Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. , 1996, Oncogene.

[29]  J. Hauber,et al.  Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study. , 1996, Human gene therapy.

[30]  M. Malim,et al.  The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal , 1996, Journal of virology.

[31]  B. Cullen,et al.  Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay , 1996, Molecular and cellular biology.

[32]  B. Cullen,et al.  Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Hauber,et al.  Inhibition of HIV-1 Replication in Lymphocytes by Mutants of the Rev Cofactor eIF-5A , 1996, Science.

[34]  Roger Y Tsien,et al.  Identification of a signal for rapid export of proteins from the nucleus , 1995, Cell.

[35]  Utz Fischer,et al.  The HIV-1 Rev Activation Domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs , 1995, Cell.

[36]  L. Gerace,et al.  Nuclear export signals and the fast track to the cytoplasm , 1995, Cell.

[37]  B. Cullen,et al.  Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins , 1995, Cell.

[38]  Michael R. Green,et al.  A human nucleoporin-like protein that specifically interacts with HIV Rev , 1995, Nature.

[39]  M. Fornerod,et al.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. , 1995, Oncogene.

[40]  J. Katahira,et al.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding , 1995, Journal of virology.

[41]  R. Tsien,et al.  Heat-stable inhibitors of cAMP-dependent protein kinase carry a nuclear export signal. , 1994, The Journal of biological chemistry.

[42]  M. Malim,et al.  The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. , 1994, Genes & development.

[43]  J. Hauber,et al.  Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans- activation , 1993, The Journal of cell biology.

[44]  T. Boulikas,et al.  Nuclear localization signals (NLS). , 1993, Critical reviews in eukaryotic gene expression.

[45]  J. Hauber,et al.  Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Malim,et al.  Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication , 1992, The Journal of experimental medicine.

[47]  J. Hauber,et al.  Expression of chimeric neo-Rev response element sequences interferes with Rev-dependent HIV-1 Gag expression. , 1992, Human gene therapy.

[48]  R. Laskey,et al.  Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.

[49]  M. Malim,et al.  Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.

[50]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.